FI900554A0 - Expressionssystem foer amidation av enzym. - Google Patents

Expressionssystem foer amidation av enzym.

Info

Publication number
FI900554A0
FI900554A0 FI900554A FI900554A FI900554A0 FI 900554 A0 FI900554 A0 FI 900554A0 FI 900554 A FI900554 A FI 900554A FI 900554 A FI900554 A FI 900554A FI 900554 A0 FI900554 A0 FI 900554A0
Authority
FI
Finland
Prior art keywords
expressionssystem
enzym
foer
amidation
amidating enzyme
Prior art date
Application number
FI900554A
Other languages
English (en)
Other versions
FI110517B (fi
Inventor
Arthur H Betelsen
Nozer M Mehta
Gary Agide Beaudry
Original Assignee
Unigene Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unigene Lab Inc filed Critical Unigene Lab Inc
Publication of FI900554A0 publication Critical patent/FI900554A0/fi
Application granted granted Critical
Publication of FI110517B publication Critical patent/FI110517B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/17—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced ascorbate as one donor, and incorporation of one atom of oxygen (1.14.17)
    • C12Y114/17003—Peptidylglycine monooxygenase (1.14.17.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Hardware Redundancy (AREA)
  • Saccharide Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI900554A 1989-02-06 1990-02-05 Amidointientsyymin ilmentämisjärjestelmät FI110517B (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/307,366 US5789234A (en) 1987-08-14 1989-02-06 Expression systems for amidating enzyme

Publications (2)

Publication Number Publication Date
FI900554A0 true FI900554A0 (fi) 1990-02-05
FI110517B FI110517B (fi) 2003-02-14

Family

ID=23189439

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900554A FI110517B (fi) 1989-02-06 1990-02-05 Amidointientsyymin ilmentämisjärjestelmät

Country Status (14)

Country Link
US (1) US5789234A (fi)
EP (1) EP0382403B1 (fi)
JP (1) JPH0771498B2 (fi)
KR (1) KR0157983B1 (fi)
AT (1) ATE283922T1 (fi)
CA (1) CA2009306C (fi)
DE (1) DE69034179T2 (fi)
DK (1) DK0382403T3 (fi)
ES (1) ES2235149T3 (fi)
FI (1) FI110517B (fi)
HU (1) HU220464B1 (fi)
LT (1) LT4077B (fi)
NO (1) NO900531L (fi)
RU (1) RU2129606C1 (fi)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789234A (en) * 1987-08-14 1998-08-04 Unigene Laboratories, Inc. Expression systems for amidating enzyme
US5912014A (en) * 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
HUP0001272A3 (en) * 1997-04-16 2012-12-28 Unigene Lab Inc Direct expression of peptides into culture media
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
US8603781B2 (en) * 2003-09-25 2013-12-10 Monsanto Technology Llc Prevention of incorporation of non-standard amino acids into protein
US7531518B2 (en) * 2004-05-14 2009-05-12 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US7648965B2 (en) 2004-05-14 2010-01-19 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US20060089723A1 (en) * 2004-10-25 2006-04-27 Murphy Kieran P Method for bone augmentation
US7445911B2 (en) 2004-11-24 2008-11-04 Unigene Laboratories Inc. Enzymatic reactions in the presence of keto acids
DE102004058306A1 (de) * 2004-12-01 2006-07-27 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Carboxy-terminal amidierten Peptiden
EP1861507A4 (en) * 2005-02-04 2008-06-25 Glaxo Group Ltd OPTIMIZATION OF THE EXPRESSION OF HETEROLOGOUS POLYPEPTIDES
PA8660701A1 (es) 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
US20060293667A1 (en) * 2005-05-19 2006-12-28 Agnes Vignery Bone implant device and methods of using same
DK1907561T3 (da) * 2005-06-24 2013-12-02 Enteris Biopharma Inc Cellelinjer til ekspression af enzym, der er anvendeligt i fremstillingen af amiderede produkter
US8377863B2 (en) 2007-05-29 2013-02-19 Unigene Laboratories Inc. Peptide pharmaceutical for oral delivery
KR20110119707A (ko) 2009-01-22 2011-11-02 유니진 래보러토리즈 인코포레이티드 비만 치료
WO2011067283A1 (en) 2009-12-01 2011-06-09 Novo Nordisk A/S Novel peptidyl alpha-hydroxyglycine alpha-amidating lyases
TW201138808A (en) 2010-05-03 2011-11-16 Bristol Myers Squibb Co Serum albumin binding molecules
CA2839298C (en) 2011-06-15 2021-05-18 Angelo P. Consalvo Anti-inflammatory pharmaceutical products
ES2586805T3 (es) 2011-11-02 2016-10-19 Keybioscience Ag Análogos de péptidos para tratar enfermedades y trastornos
BR112014010701A2 (pt) 2011-11-02 2020-06-23 Keybioscience Ag Uso de um peptídeo
US9533022B2 (en) 2011-11-02 2017-01-03 KeyBioscience A/S Peptide analogs for treating diseases and disorders
CA2904327C (en) 2013-03-05 2021-06-08 Enteris Biopharma, Inc. Pharmaceuticals for oral delivery
ES2660788T3 (es) 2013-11-14 2018-03-26 Keybioscience Ag Miméticos de la calcitonina para el tratamiento de enfermedades y trastornos
CA2932408A1 (en) 2013-12-02 2015-06-11 Stealth Biotherapeutics Corp Compositions and methods for treating vitiligo
EP3148565A4 (en) 2014-05-28 2018-06-06 Stealth Biotherapeutics Corp Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
WO2015183988A1 (en) 2014-05-28 2015-12-03 Stealth Peptides International, Inc. Therapeutic compositions including therapeutic small molecules and uses thereof
WO2015195737A1 (en) 2014-06-17 2015-12-23 Stealth Peptides International, Inc. Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening
GB201500263D0 (en) 2015-01-08 2015-02-25 Keybioscience Ag Calcitonin analogues for treating diseases and disorders
CN107427469B (zh) 2015-01-12 2021-01-26 安特里斯生物制药公司 固体口服剂型
GB201704429D0 (en) 2017-03-21 2017-05-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
GB201707955D0 (en) 2017-05-18 2017-07-05 Keybioscience Ag Dual amylin and calcitonin receptor agonists for treating diseases and disorders
GB201813677D0 (en) 2018-08-22 2018-10-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
GB201813678D0 (en) 2018-08-22 2018-10-03 Keybioscience Ag Acylated calcitonin mimetics
WO2021026854A1 (zh) * 2019-08-15 2021-02-18 中国科学院微生物研究所 一种酶催化的蛋白质c-端选择性酰肼化修饰方法
GB202001024D0 (en) 2020-01-24 2020-03-11 Key Bioscience Ag Oxyntomodulin mimetics

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3484377D1 (de) * 1983-06-15 1991-05-08 Celltech Ltd Peptide, pharmazeutische zusammensetzungen, gene, vektoren, wirtorganismen, verfahren zu deren herstellung und diagnostische reagenzien.
DE3327007A1 (de) * 1983-07-27 1985-02-07 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit einem saeureamid-carboxyterminus
US4708934A (en) * 1984-09-27 1987-11-24 Unigene Laboratories, Inc. α-amidation enzyme
US6319685B1 (en) * 1984-09-27 2001-11-20 Unigene Laboratories, Inc. Alpha-amidating enzyme compositions and processes for their production and use
JPS6229997A (ja) * 1985-04-08 1987-02-07 Sankyo Co Ltd Ｃ末端にプロリンアミドを有するペプチドの製法
JPS62177184A (ja) * 1986-01-29 1987-08-04 Toyota Motor Corp 鋳鉄製内燃機関用シリンダヘツドおよびその製造方法
JPH0775541B2 (ja) * 1986-06-07 1995-08-16 壽之 松尾 Ｃ末端アミド化酵素及びその製造方法
EP0249477A3 (en) * 1986-06-12 1988-01-20 Immunex Corporation Functional recombinant analog polypeptides devoid of hydrophobic amino acids
JP2598050B2 (ja) * 1987-07-17 1997-04-09 サントリー株式会社 Ｃ−末端α−アミド化酵素
US5789234A (en) * 1987-08-14 1998-08-04 Unigene Laboratories, Inc. Expression systems for amidating enzyme
US6255067B1 (en) * 1987-09-15 2001-07-03 The Johns Hopkins University cDNA encoding peptidyl-glycine alpha-amidating monooxygenase (PAM)
JP2535398B2 (ja) * 1989-01-17 1996-09-18 サントリー株式会社 アミド化ペプチドの製造方法
JP2845468B2 (ja) * 1989-01-17 1999-01-13 サントリー株式会社 ヒト甲状腺由来Ｃ―末端α―アミド化酵素

Also Published As

Publication number Publication date
KR0157983B1 (ko) 1998-11-16
KR900013078A (ko) 1990-09-03
US5789234A (en) 1998-08-04
DE69034179D1 (de) 2005-01-05
ES2235149T3 (es) 2005-07-01
JPH0771498B2 (ja) 1995-08-02
DE69034179T2 (de) 2005-12-01
HU220464B1 (hu) 2002-02-28
DK0382403T3 (da) 2005-03-21
EP0382403A2 (en) 1990-08-16
NO900531D0 (no) 1990-02-05
NO900531L (no) 1990-08-07
HUT54414A (en) 1991-02-28
CA2009306C (en) 2002-04-09
EP0382403A3 (en) 1991-04-10
CA2009306A1 (en) 1990-08-06
HU900226D0 (en) 1990-03-28
FI110517B (fi) 2003-02-14
JPH0541982A (ja) 1993-02-23
LTIP1829A (en) 1995-08-25
RU2129606C1 (ru) 1999-04-27
EP0382403B1 (en) 2004-12-01
LT4077B (en) 1996-12-27
ATE283922T1 (de) 2004-12-15

Similar Documents

Publication Publication Date Title
FI900554A0 (fi) Expressionssystem foer amidation av enzym.
FI20011797A (fi) TAKA-amylaasipromoottori
ES2171398T3 (es) Acidos nucleicos viricos vegetales recombinantes.
WO2001014539A3 (en) Methods and compositions for the construction and use of fusion libraries
ATE64619T1 (de) Menschliches apolipoprotein a1 sowie dessen variante, exprimiert in escherichia coli.
ATE364083T1 (de) Immunogene zusammensetzungen gegen eine helicobacterinfektion, verwendung von polypeptiden in diesen zusammensetzungen und nukleinsäurendie besagte polypeptide kodieren
FI923758A0 (fi) Expressionssystem.
EP0331356A3 (en) Expression of hiv binding proteins
DE3679874D1 (de) Wirt-vektor-system.
FI971377A (fi) Adenovirusperäisiä virusvektoreita, joissa on kaksi terapeuttista geeniä: itsemurha- ja immuunistimuloiva geeni
CA2088478A1 (en) Cloning and expression of a rhoptry associated protein of p. falciparum
EP0197797A3 (en) Improved recombinant hosts, their production and use
SE8800981A (sv) A recombinant fusion protein, its use and a recombinant vector
IT1262957B (it) Procedimento di produzione della proteina sv-iv ricombinante e proteina sv-iv ricombinante.
SE9101740D0 (sv) Nya dna fragment och sekvenser

Legal Events

Date Code Title Description
FG Patent granted

Owner name: UNIGENE LABORATORIES, INC.